Dorsolateral prefrontal cortex N-acetylaspartate/total creatine (NAA/tCr) loss in male recreational cannabis users

被引:96
作者
Hermann, Derik
Sartorius, Alexander
Welzel, Helga
Walter, Sigrid
Skopp, Gisela
Ende, Gabriele
Mann, Karl
机构
[1] Cent Inst Mental Hlth, D-6800 Mannheim, Germany
[2] Heidelberg Univ, Inst Forens & Traff Med, Heidelberg, Germany
关键词
cannabidiol; cannabis; DLPFC; MRSI; neuropsychological; THC;
D O I
10.1016/j.biopsych.2006.08.027
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Cannabinoids present neurotoxic and neuroprotective properties in in vitro studies, inconsistent alterations in human neuroimaging studies, neuropsychological deficits, and an increased risk for psychotic episodes. Methods: Proton magnetic resonance spectroscopy (H-1-MRS), neuropsychological testing, and hair analysis for cannabinoids was performed in 13 male nontreatment-seeking recreational cannabis users and 13 male control subjects. Results: A significantly diminished N-acetylaspartate/total creatine (NAA/tCr) ratio in the dorsolateral prefrontal cortex (DLPFC) was observed in cannabis users (p =.0003). The NAA/tCr in the putamen/globus pallidum region correlated significantly with cannabidiol (R-2 =.66, p =.004). Results of the Wisconsin Card Sorting test, Trail making Test, and D2 test for attention were influenced by cannabinoids. Conclusions: Chronic recreational cannabis use is associated with an indication of diminished neuronal and axonal integrity in the DLPFC in this study. As chronic cannabis use is a risk factor for psychosis, these results are interesting because diminished NAA/tCr ratios in the DLPFC and neuropsychological deficits were also reported in schizophrenia. The strong positive correlation of NAA/tCr and cannabidiol in the putamen/globus pallidum is in line with neuroprotective properties of cannabidiol, which were also observed in in vitro model studies of Parkinson's disease.
引用
收藏
页码:1281 / 1289
页数:9
相关论文
共 74 条
[1]   The effects of cannabinoids on the brain [J].
Ameri, A .
PROGRESS IN NEUROBIOLOGY, 1999, 58 (04) :315-348
[2]  
[Anonymous], WIP REDUZIERTER WECH
[3]  
Armitage SG, 1946, PSYCHOL MONOGR, V60, P1
[4]   The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia [J].
Bertolino, A ;
Callicott, JH ;
Mattay, VS ;
Weidenhammer, KM ;
Rakow, R ;
Egan, MF ;
Weinberger, DR .
BIOLOGICAL PSYCHIATRY, 2001, 49 (01) :39-46
[5]   Working in memory deficits and levels of N-acetylaspartate patients with schizophreniform disorder [J].
Bertolino, A ;
Sciota, D ;
Brudaglio, F ;
Altamura, M ;
Blasi, G ;
Bellomo, A ;
Antonucci, N ;
Callicott, JH ;
Goldberg, TE ;
Scarabino, T ;
Weinberger, DR ;
Nardini, M .
AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (03) :483-489
[6]   Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study [J].
Blasi, G ;
Bertolino, A ;
Brudaglio, F ;
Sciota, D ;
Altamura, M ;
Antonucci, N ;
Scarabino, T ;
Weinberger, DR ;
Nardini, M .
PSYCHIATRY RESEARCH-NEUROIMAGING, 2004, 131 (02) :95-105
[7]   Role of phospholipase A2 on the variations of the choline signal intensity observed by 1H magnetic resonance spectroscopy in brain diseases [J].
Boulanger, Y ;
Labelle, M ;
Khiat, A .
BRAIN RESEARCH REVIEWS, 2000, 33 (2-3) :380-389
[8]  
BRINCKENKAMP R, 1994, D2 AUFMERKSAMKEITS B
[9]   Selective relationship between prefrontal N-acetylaspartate measures and negative symptoms in schizophrenia [J].
Callicott, JH ;
Bertolino, A ;
Egan, MF ;
Mattay, VS ;
Langheim, FJP ;
Weinberger, DR .
AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (10) :1646-1651
[10]   Hippocampal neurotoxicity of Δ9-tetrahydrocannabinol [J].
Chan, GCK ;
Hinds, TR ;
Impey, S ;
Storm, DR .
JOURNAL OF NEUROSCIENCE, 1998, 18 (14) :5322-5332